Further development of intensive care in patients with acute psychodysleptic poisoning
https://doi.org/10.31549/2542-1174-2020-3-39-51
Abstract
Acute psychodysleptic poisoning is accompanied with the activation of anaerobic processes, development of hypoxia, rhabdomyolysis and an inflammatory reaction, which ultimately determines the occurrence of complications (cerebral ischemia, hypotension, hepatorenal syndrome, pneumonia, etc.). In order to improve the intensive care of patients with acute psychodysleptic poisoning, a study was carried out in which 148 patients with acute psychodysleptic poisoning participated. The control group consisted of 75 patients who received conventional therapy in accordance with Federal Clinical Guidelines. The study group included 73 patients who were additionally prescribed ethylmethylhydroxypyridine succinate (mexidol).
Acute psychodysleptic poisoning, even mild, is accompanied by the development of metabolic disorders that cannot be corrected by standard therapy, despite the consciousness recovery and relief of tachycardia. Acute psychodysleptic poisoning of moderate severity is characterized by the development of anaerobic processes, hepatorenal syndrome and inflammatory response. Conventional therapy could not stop the pathological reactions in a short time. Additional use of mexidol contributed to a decrease in the intensity of anaerobic processes and the elimination of metabolic disorders, which made it possible to shorten the rehabilitation period by 3–4 times.
About the Authors
А. N. LodyaginRussian Federation
Lodyagin Aleksey Nikolayevich — Dr. Sci. (Med.), Head, Clinical Toxicology Department
Е. А. Rakhmanova
Russian Federation
Rakhmanova Ekaterina Andreyevna — Assistant, Department of Mobilization Training of Health Care, Disaster Medicine and Ambulance with the Postgraduate Course (PC); Anesthesiologist-Resuscitator, Acute Poisoning Department
Е. А. Popova
Russian Federation
Popova Elena Anatolyevna — Dr. Sci. (Med.), Professor, Department of Mobilization Training of Health Care, Disaster Medicine and Ambulance with PC; Anesthesiologist-Resuscitator, Acute Poisoning Department
B. V. Batotzyrenov
Russian Federation
Batotzyrenov Bair Vasilyevich — Dr. Sci. (Med.), Chief Researcher, Department of Clinical Toxicology
3A, Budapeshtskaya str., Saint-Petersburg, 192242
А. А. Popov
Russian Federation
Popov Andrey Alekseevich — Dr. Sci. (Med.), Professor, Department of Mobilization Training of Health Care, Disaster Medicine and Ambulance with PC; Curator, Intensive Care Unit No. 5
M. А. Bolshakova
Russian Federation
Bolshakova Mariya Andreyevna — Cand. Sci. (Med.), Associate Professor, Department of Mobilization Training of Health Care, Disaster Medicine and Ambulance with PC; Anesthesiologist-Resuscitator, Intensive Care Unit No. 5
R. M. Rakhmanov
Russian Federation
Rakhmanov Roman Mikhailovich — Assistant, Department of Mobilization Training of Health Care, Disaster Medicine and Ambulance with PC; AnesthesiologistResuscitator, Intensive Care Unit No. 5
References
1. Aizberg О.R., Shileyko I.D., Liskovskiy О.V. (2018). New psychoactive substances. Medical Journal, 4, 4–9.
2. Vandrey R., Dunn K.E., Fry J.A., Girling E.R. (2012). A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend., 120 (1–3), 238–241.
3. Nobis F. (2012). “Legal-High”-Produkte — wirklich illegal? Neue Zeitschrift für Strafrech., 8, 422–425.
4. Lipari R. (2013, Jan 3). The CBHSQ Report. Trends in Adolescent Substance Use and Perception of Risk from Substance Use. Retrieved Sept. 29, 2019 from https://www.ncbi.nlm.nih.gov/books/NBK385059/pdf/Bookshelf_NBK385059.pdf.
5. Egorov А.Yu. (2018). Design drugs: a new problem in adolescent addictology. Mental Health of Children and Adolescent, 18 (2), 83–91.
6. Zobnin Y.V., Stadler Е.м. (2014). Acute poisoning with synthetic cannabinoids (“Spice”). Siberian Medical Journal (Irkutsk), 131 (8), 130–135.
7. Gromova О.А., Torshin I.Yu., Stelmashuk E.V. et al. (2017). A study of the neuroprotective effect of mexidol on the cell model of glutamate stress. S.S. Korsakov Journal of Neurology and Psychiatry, 117 (12), 71–77.
8. Makiev G.G., Gurina А.Е., Gabolaeva N.А. (2018). Influence of mexidol on condition of the pro- and antioxidant systems in experimental acute respiratory distress syndrome. Problems of Biological, Medical and Pharmaceutical Chemistry, 21 (8), 52–57.
9. Ostapenko Yu.N. (ed.) (2013). Federal Clinical Guidelines. Poisoning by Psychotropic Drugs, not Elsewhere Classified, 38 p. In Russ.
10. Vetsheva м.S., Podkorytova О.L., Kotenko О.N. et al. (2015). Integral scales and its importance in reducing mortality in patients in critical condition. Medical Alphabet, 3 (14), 6–11.
11. Sinevich А.А., Kopytov А.V. (2016). An analysis of psychopathological symptomatology of emotional-behavioural registry (using PANSS) in male smoking blends addicts from Belarus. Military Medicine, 3, 64–70.
12. Khalimov Yu.Sh, Bekmukhametov А.F., Kuzmich V.G. (2016). Prospects for the use of a scale assessment of the severity and the prognosis of victims during the elimination of the medical and sanitary consequences of emergency situations. The experience of using the forces and means of the medical service of the Armed Forces of the Russian Federation’s Ministry of Defense in the elimination of the medical and sanitary consequences of emergency situations: Materials of the AllArmy Scientific and Practical. Conf. Saint-Petersburg, pp. 252–254. In Russ.
Review
For citations:
Lodyagin А.N., Rakhmanova Е.А., Popova Е.А., Batotzyrenov B.V., Popov А.А., Bolshakova M.А., Rakhmanov R.M. Further development of intensive care in patients with acute psychodysleptic poisoning. Journal of Siberian Medical Sciences. 2020;(3):39-51. https://doi.org/10.31549/2542-1174-2020-3-39-51